scholarly journals Small Cell Cancer of the Bladder and Prostate: A Retrospective Review from a Tertiary Cancer Center

Cureus ◽  
2015 ◽  
Author(s):  
Shahida Ahmed ◽  
Sam Neufeld ◽  
Tadeusz J Kroczak ◽  
Bashir Bashir ◽  
Naseer Ahmed ◽  
...  
Keyword(s):  
Retrospective Review ◽  
Cell Cancer ◽  
Small Cell ◽  
Cancer Center ◽  
Small Cell Cancer ◽  
Cancer Of The Bladder ◽  
Tertiary Cancer Center

Small cell cancer of the bladder: The Léon-Bérard Cancer Center experience

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 16147-16147
Author(s):  
I. N. Nabil ◽  
F. Elkarak ◽  
A. Flechon ◽  
J. Droz
Keyword(s):  
Cell Cancer ◽  
Small Cell ◽  
Cancer Center ◽  
Small Cell Cancer ◽  
Cancer Of The Bladder

scholarly journals Small cell cancer of the bladder: The Leon-Berard cancer centre experience

2008 ◽  
Vol 24 (4) ◽  
pp. 494 ◽  
Author(s):  
Nabil Ismaili ◽  
Fadi Elkarak ◽  
PierreEtienne Heudel ◽  
Aude Flechon ◽  
JeanPierre Droz
Keyword(s):  
Cell Cancer ◽  
Small Cell ◽  
Cancer Centre ◽  
Small Cell Cancer ◽  
Cancer Of The Bladder

Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosis

2009 ◽  
Vol 96 (6) ◽  
pp. E30-E44 ◽  
Author(s):  
N. Ismaili ◽  
S. Arifi ◽  
A. Flechon ◽  
O. El Mesbahi ◽  
J.-Y. Blay ◽  
...  
Keyword(s):  
Cell Cancer ◽  
Small Cell ◽  
Small Cell Cancer ◽  
Cancer Of The Bladder ◽  
Bladder Pathology

Retrospective review of paclitaxel beyond second-line therapy in patients with small cell cancer.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e18549-e18549
Author(s):  
Tricia L. Kalwar ◽  
Haralambos Raftopoulos ◽  
Doru Paul ◽  
Craig E. Devoe ◽  
Nina Kohn ◽  
...  
Keyword(s):  
Retrospective Review ◽  
Cell Cancer ◽  
Small Cell ◽  
Second Line ◽  
Second Line Therapy ◽  
Small Cell Cancer ◽  
Line Therapy

Analysis of treatment for small cell cancer of the bladder and report of three cases

Urology ◽  
2004 ◽  
Vol 64 (3) ◽  
pp. 494-498 ◽  
Author(s):  
Edward Karpman ◽  
Zelanna Goldberg ◽  
Amir Saffarian ◽  
Regina Gandour-Edwards ◽  
Lars M. Ellison ◽  
...  
Keyword(s):  
Cell Cancer ◽  
Small Cell ◽  
Small Cell Cancer ◽  
Cancer Of The Bladder

Clinical characteristics and treatment outcome of small cell cancer of the bladder; results from a 10-year experience from 3 UK cancer centres

2016 ◽  
Vol 42 (11) ◽  
pp. S248
Author(s):  
Caroline Chau ◽  
Rosalind Jarvis ◽  
Chern Lee ◽  
Hannah Markham ◽  
Wessam Al-Utayem ◽  
...  
Keyword(s):  
Treatment Outcome ◽  
Clinical Characteristics ◽  
Cell Cancer ◽  
Small Cell ◽  
Small Cell Cancer ◽  
Cancer Of The Bladder

Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: A case series and review of the literature

2012 ◽  
Vol 30 (2) ◽  
pp. 192-195 ◽  
Author(s):  
Rayford R. June ◽  
David W. Dougherty ◽  
Carl T. Reese ◽  
Lewis E. Harpster ◽  
Salee L. Hoffman ◽  
...  
Keyword(s):  
Cell Cancer ◽  
Single Agent ◽  
Case Series ◽  
Small Cell ◽  
Significant Activity ◽  
Second Line ◽  
Review Of The Literature ◽  
Small Cell Cancer ◽  
Cancer Of The Bladder ◽  
Line Chemotherapy

Case 2: Recurrent thromboembolism despite adequate oral anticoagulation – Trousseau’s syndrome

1999 ◽  
Vol 56 (9) ◽  
pp. 481-483
Author(s):  
Züger ◽  
Demarmels Biasiutti
Keyword(s):  
Oral Anticoagulation ◽  
Cell Cancer ◽  
Small Cell ◽  
Niedermolekulares Heparin ◽  
Small Cell Cancer ◽  
Trousseau’S Syndrome ◽  
Cancer Of The Lung

Wir berichten über einen 76jährigen Patienten, welcher trotz gut eingestellter oraler Antikoagulation mit Phenprocoumon rezidivierende Thrombosen erlitt bei leichtgradiger chronischer disseminierter intravasaler Gerinnung. Die Abklärungen ergaben das Vorliegen eines Bronchus-Karzinoms (Non small cell cancer of the lung, NSCCL) mit hilären und mediastinalen Lymphknotenmetastasen. Aufgrund der Assoziation von rezidivierenden Thrombosen, aktivierter Gerinnung und Tumorleiden wurde die Diagnose eines Trousseau Syndroms gestellt. Basierend auf Fallberichten aus der Literatur wurde die Therapie auf intravenöses Heparin gewechselt, welches die thrombotische Koagulopathie stoppte. Aus praktischen Gründen erfolgte dann eine Umstellung der Therapie auf subcutanes niedermolekulares Heparin in therapeutischer Dosierung, welches während 6.5 Monaten ebenso effektiv war und eine Alternative zur etablierten Therapie mit unfraktioniertem Heparin bei Trousseau Syndrom darstellen dürfte.

Stage IV Lung Non-Small Cell Cancer AJCC v7

2020 ◽  
Author(s):  
Keyword(s):  
Cell Cancer ◽  
Stage Iv ◽  
Small Cell ◽  
Small Cell Cancer
Sign in / Sign up

Export Citation Format

Share Document